Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement.
GREATER BOSTON CHAMBER OF COMMERCE: Greater Boston Chamber of Commerce and Health Connector for Business Kickoff Small Business Week with Partnership to Better Empower Small Businesses to Access Affordable Health Insurance
Working to empower small businesses to access affordable health insurance for employees, the Greater Boston Chamber of Commerce (GBCC) kicks off National Small Business Week by announcing a new partnership with the Health Connector for Business that delivers cost-saving opportunities to employers and health care insurance choice to employees.
EVERSOURCE ENERGY: Greater Boston Food bank and Eversource Partner to cut Energy Consumption at Yawkey Distribution Center
The Greater Boston Food Bank is starting the year off with a 75 percent reduction in energy use during targeted peak hours and substantial cost savings thanks to a partnership with Eversource and the installation of a new Viking Cold Solutions thermal energy storage (TES) system.
Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire the remaining shares of Millipede, Inc, a privately-held company in Santa Rosa, Calif., upon its recent successful completion of a first-in-human clinical study.
ALKU and Holland Square Group (HSG), an ALKU Company, are excited to announce that HSG’s Security Division will operate completely as ALKU in the new year!
Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc. (LSE: BTG), a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals.
Veristat, a full-service Clinical Research Organization (CRO), announced today that it has partnered with Triumph Research Intelligence (TRI), a global leader providing technology and solutions for centralized and risk-based monitoring (RBM) to improve clinical trial quality and compliance.
Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately begin work on part one of a Phase 2B dose-ranging, efficacy study for their lead drug candidate ATB-346.
Acquia and BigCommerce today announced a partnership to help merchants develop and launch online ecommerce solutions with powerful, on-brand customer experiences.
Acquia and Elastic Path today announce a partnership to help brands realize the opportunities of open source content management and headless commerce solutions.
BrainSell Technologies, a value-added reseller (VAR) that specializes in end-to-end business software technologies and unbiased consulting and implementation services for organizations of all sizes, today announced a new partnership with HubWise Technology.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Augmenix, Inc., a privately-held company that developed and commercialized the SpaceOAR® Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer.
ALKU a highly specialized consulting services firm, has expanded their niche industries to include ServiceNow contract services.
Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the SpaceOAR® System, a therapy used to reduce common and debilitating side effects that men may experience after receiving prostate cancer radiotherapy.